Skip to content
Subscribe
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Newsletter
Drug Development
Blog Post
Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD
By
Sujatha Gurunathan
|
August 10, 2022
Blog Post
Simply Stated: What is Myasthenia Gravis (MG)?
By
Sujatha Gurunathan
|
June 27, 2022
Blog Post
Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS
By
Sujatha Gurunathan
|
June 1, 2022
Blog Post
Clinical Trial Alert: Phase 3 Study of investigational drug in Adults Living with ALS
By
Sujatha Gurunathan
|
May 17, 2022
Featured Article
Understanding Amyotrophic Lateral Sclerosis
By
MDA Staff
|
May 13, 2022
Featured Article
A Successful In-Person Conference
By
MDA Staff
|
May 13, 2022
Blog Post
Simply Stated: Inclusion Body Myositis, Revisited
By
Sujatha Gurunathan
|
April 27, 2022
Blog Post
Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG
By
MDA Staff
|
April 6, 2022
Blog Post
Clinical Trial Alert: Phase 2 Study of Ravulizumab (Ultomiris) in Adults Living with Dermatomyositis
By
MDA Staff
|
April 5, 2022
Blog Post
2022 Clinical & Scientific Conference: March 16 Highlights
By
Sujatha Gurunathan
|
March 16, 2022
1
2
3
…
11
Next »
Skip to content
Open toolbar
Accessibility Tools
Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset